Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of montelukast, an approved medication,
on the lower leg growth rate in children with mild asthma. The primary hypothesis is that the
lower leg length (LLL) growth rate for children treated with montelukast compared to placebo
will be established.